Source link : https://www.newshealth.biz/health-news/real-world-use-of-long-acting-cabotegravir-for-prep/
Real-world data presented at the 2024 IDWeek annual meeting in Los Angeles highlighted the effectiveness of long-acting (LA) cabotegravir (Apretude) for HIV prevention. Over the first 2 years of use in the U.S., cabotegravir as pre-exposure prophylaxis (PrEP) was associated with high adherence, persistence, and safety in at-risk adults and adolescents. In this MedPage Today […]
Author : News Health
Publish date : 2024-11-06 18:06:51
Copyright for syndicated content belongs to the linked Source.